Liver health may change how prostate drug works
NCT ID NCT06860243
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study looked at how the experimental prostate cancer drug opevesostat stays in the body over time. Researchers compared 16 men with moderate liver impairment to healthy men. The goal was to see if liver problems affect drug levels, which helps doctors decide on safe dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Pharmacology of Miami ( Site 0002)
Miami, Florida, 33172, United States
-
Texas Liver Institute ( Site 0001)
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.